Connor, Clark & Lunn Investment Management (CC&L)’s GoodRx Holdings GDRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.32M | Buy |
1,671,521
+236,896
| +17% | +$1.18M | 0.03% | 442 |
|
2025
Q1 | $6.33M | Buy |
1,434,625
+205,789
| +17% | +$908K | 0.03% | 439 |
|
2024
Q4 | $5.71M | Buy |
1,228,836
+342,781
| +39% | +$1.59M | 0.03% | 451 |
|
2024
Q3 | $6.15M | Sell |
886,055
-151,465
| -15% | -$1.05M | 0.03% | 390 |
|
2024
Q2 | $8.09M | Sell |
1,037,520
-73,217
| -7% | -$571K | 0.03% | 316 |
|
2024
Q1 | $7.89M | Buy |
1,110,737
+277,381
| +33% | +$1.97M | 0.03% | 339 |
|
2023
Q4 | $5.58M | Buy |
833,356
+97,154
| +13% | +$651K | 0.03% | 391 |
|
2023
Q3 | $4.14M | Sell |
736,202
-84,179
| -10% | -$474K | 0.02% | 442 |
|
2023
Q2 | $4.53M | Buy |
820,381
+120,376
| +17% | +$664K | 0.02% | 418 |
|
2023
Q1 | $4.38M | Buy |
700,005
+408,405
| +140% | +$2.55M | 0.02% | 395 |
|
2022
Q4 | $1.36M | Buy |
+291,600
| New | +$1.36M | 0.01% | 630 |
|